Pricing Log in Create free account

Talphera, Inc. (TLPH) vs Zhengye Biotechnology Holding Limited (ZYBT)

Talphera, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $52.4M against $41.0M — 1.3× the size. Across the 7 metrics below, Zhengye Biotechnology Holding Limited leads on 4 and Talphera, Inc. on 3.

Valuation

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 180.84 — 2.08
P/B 5.35 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 155.68 n/m 2.87
Earnings yield (26.47%) — (15.94%)
Free cash flow yield (12.52%) 0.00% 0.00%

Profitability

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 100.00% — 53.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.36%) 0.00% (0.80%)
Return on assets (69.60%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (73.07%) — 5.22%
EPS growth (last fiscal year) 32.00% (800.00%) 42.91%
Revenue growth, 5-year CAGR (58.55%) — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.04
Current ratio 4.29 1.14 2.41
Net debt to EBITDA 1.50 (0.51) 1.01

Dividend

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Market cap 52.42m 41.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack